Clinical Trial Update: Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, The ERASur Study [Phase 3]

View source ↗

Summary

Phase 3 trial update for the ERASur study evaluating adding Total Ablative Therapy to standard systemic therapy in limited metastatic colorectal cancer; current…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Metastatic Colorectal Adenocarcinoma, Stage IV Colorectal Cancer AJCC v8 | Phase 3 | Status: RECRUITING